Pages that link to "Q27009305"

The following pages link to New insights into iron regulation and erythropoiesis (Q27009305):

Displaying 40 items.

• Pharmacological Targeting of the Hepcidin/Ferroportin Axis (Q26738350) (← links)
• Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review (Q26750731) (← links)
• Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic Effects (Q26752455) (← links)
• Iron Homeostasis in Health and Disease (Q26775146) (← links)
• Cellular sensing and transport of metal ions: implications in micronutrient homeostasis. (Q36244852) (← links)
• Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women (Q36653945) (← links)
• Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress (Q38438082) (← links)
• Experimental and investigational therapies for chemotherapy-induced anemia. (Q38584639) (← links)
• HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond (Q38666170) (← links)
• New strategies to target iron metabolism for the treatment of beta thalassemia (Q38751490) (← links)
• Protein-based therapeutic for anemia caused by dyserythropoiesis. (Q38818403) (← links)
• Investigational therapies for renal disease-induced anemia (Q38819455) (← links)
• Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development (Q38988198) (← links)
• Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker (Q39247857) (← links)
• Iron Metabolism and the Inflammatory Response. (Q39285336) (← links)
• Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing (Q40709924) (← links)
• Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. (Q41594444) (← links)
• Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss (Q42038630) (← links)
• Jekyll and Hyde: the role of heme oxygenase-1 in erythroid biology (Q42573904) (← links)
• Role of growth differentiation factor 11 in development, physiology and disease (Q44296589) (← links)
• Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice. (Q47101427) (← links)
• Iron status of North American pregnant women: an update on longitudinal data and gaps in knowledge from the United States and Canada (Q47603629) (← links)
• What can we learn from ineffective erythropoiesis in thalassemia? (Q47885433) (← links)
• Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models (Q49758040) (← links)
• Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult (Q50073791) (← links)
• Hepcidin agonists as therapeutic tools. (Q52663760) (← links)
• Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes. (Q55384284) (← links)
• Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder (Q58587214) (← links)
• Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice (Q58793901) (← links)
• Tissue iron is negatively correlated with TERC or TERT mRNA expression: A heterochronic parabiosis study in mice (Q60952686) (← links)
• A computational model to understand mouse iron physiology and disease (Q61451281) (← links)
• Molecular perspective of iron uptake, related diseases, and treatments (Q64064176) (← links)
• Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis (Q64086687) (← links)
• Relationship of Iron Metabolism and Short-Term Cuprizone Treatment of C57BL/6 Mice. (Q64928017) (← links)
• Correction of Anemia in Chronic Kidney Disease With Angelica sinensis Polysaccharide via Restoring EPO Production and Improving Iron Availability. (Q64981461) (← links)
• Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents (Q88408932) (← links)
• Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload (Q89700536) (← links)
• New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia (Q91813353) (← links)
• Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease (Q92453774) (← links)
• Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents (Q93052579) (← links)